Question normal

In ABSORB III trial, the TLF at one year for Xience and the BRS Absorb was not significantly different. There was also no difference reported in cardiac death, target vessel myocardial infarction, ischemia-driven TLR or thrombosis. How long do the trials need to go out to show the benefit of absorption?